CAN B (CANB) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 163 245 sessions, September 13, 2024 to September 15, 2025
- Largest daily move
- +131.3% close of September 23, 2024
- 1-year change
- +74.8% closing prices, September 13, 2024 to September 15, 2025
- 5-year change
- -99.7% closing prices, September 15, 2020 to September 15, 2025
Company Description
CAN B (OTC: CANB) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.4M.
CANB has gained 74.8% over the past year. The last closing price was $0.0180.
For FY2023, CAN B reported revenue of $2.2M with net income of -$9.7M and diluted earnings per share of -$0.77. The company operates at a net profit margin of -451.7%.
This page collects what Stock Titan holds for CANB, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CAN B (CANB) closed at $0.0180 on September 15, 2025. Over the past 12 months, the price has gained 74.8%.
CANB Metrics & Rankings
Price returns through September 15, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
CAN B has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences. View all CANB news →
SEC Filings
Financial Highlights
CAN B generated $2.2M in revenue in FY2023, retaining a 16.6% gross margin, operating income reached -$7.5M (-347.3% operating margin), and net income was -$9.7M, reflecting a -451.7% net profit margin. Diluted earnings per share stood at -$0.77. The company generated -$1.3M in operating cash flow. With a current ratio of 0.45, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
CANB Company Profile & Sector Positioning
CAN B (CANB) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CANB often look at related companies in the same sector, including CBD OF DENVER INC (CBDD), OVATION SCIENCE INC (OVATF), SOFTWARE EFF SLTNS CORP (SFWJ), CITY VIEW GREENN HLDGS (CVGRF), and WEST ISLAND BRANDS INC (WIBFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CANB's relative position within its industry.